Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epinastine hydrochloride eye drops vs emedastine fumarate for allergic conjunctivitis
CTR20231572Phase 3Completed
- Sponsor
- Runer Pharmaceutical
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of epinastine in allergic conjunctivitis (AC), sponsored by Runer Pharmaceutical. Started May 2023; status: completed.
02
Drugs
epinastine
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on CTR20231572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231572.